<?xml version="1.0" encoding="UTF-8"?>
<p>Clinical manifestations in pediatric patients have not been systematically described. Among the 31 pediatric patients with MERS-CoV infection documented from June 2012 to April 19, 2016, 13 patients (42%) were asymptomatic [
 <xref rid="CIT0094" ref-type="bibr">94</xref>]. In another study, among 7 pediatric patients identified from April 2014 to November 2016, 3 were asymptomatic; fever, cough, shortness of breath, diarrhea, and vomiting were observed in 4 patients [
 <xref rid="CIT0095" ref-type="bibr">95</xref>]. Although pediatric patients typically have mild disease, high-risk children with underlying conditions, including cystic fibrosis, nephrotic syndrome, and unidentified underlying conditions, died of MERS-CoV infection, with a fatality rate of 12% (4/33) (see 
 <xref ref-type="supplementary-material" rid="sup1">Supplementary Table 1</xref>) [
 <xref rid="CIT0096" ref-type="bibr">96</xref>, 
 <xref rid="CIT0097" ref-type="bibr">97</xref>].
</p>
